Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 28,647

Sort by:

Aldose Reductase (Aldehyde Reductase or Aldo Keto Reductase Family 1 Member B1 or AKR1B1 or EC 1.1.1.21) - Drugs in Development, 2021

US$ 3,000.00

Aldose Reductase (Aldehyde Reductase or Aldo Keto Reductase Family 1 Member B1 or AKR1B1 or EC 1.1.1.21) - Drugs in Development, 2021 SUMMARY Aldose Reductase (Aldehyde Reductase or Aldo Keto Reductas...

April 2021 35 pages

ALK Tyrosine Kinase Receptor (Anaplastic Lymphoma Kinase or CD246 or ALK or EC 2.7.10.1) - Drugs in Development, 2021

US$ 3,000.00

ALK Tyrosine Kinase Receptor (Anaplastic Lymphoma Kinase or CD246 or ALK or EC 2.7.10.1) - Drugs in Development, 2021 SUMMARY ALK Tyrosine Kinase Receptor (Anaplastic Lymphoma Kinase or CD246 or ALK o...

April 2021 70 pages

Alkaline Phosphatase (ALKP or Phosphomonoesterase or Glycerophosphatase or Alkaline Phosphohydrolase or EC 3.1.3.1) - Drugs in Development, 2021

US$ 3,000.00

Alkaline Phosphatase (ALKP or Phosphomonoesterase or Glycerophosphatase or Alkaline Phosphohydrolase or EC 3.1.3.1) - Drugs in Development, 2021 SUMMARY Alkaline Phosphatase (ALKP or Phosphomonoestera...

April 2021 35 pages

Allergic Asthma (Respiratory) - Drugs in Development, 2021

US$ 2,000.00

Allergic Asthma (Respiratory) - Drugs in Development, 2021 SUMMARY Allergic Asthma (Respiratory) - Drugs in Development, 2021 provides an overview of the Allergic Asthma pipeline landscape. The report...

April 2021 115 pages

Allergic Bronchopulmonary Aspergillosis (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Allergic Bronchopulmonary Aspergillosis (Infectious Disease) - Drugs in Development, 2021 SUMMARY Allergic Bronchopulmonary Aspergillosis (Infectious Disease) - Drugs in Development, 2021 provides an...

April 2021 35 pages

Allergic Rhino-Conjunctivitis (Ophthalmology) - Drugs in Development, 2021

US$ 2,000.00

Allergic Rhino-Conjunctivitis (Ophthalmology) - Drugs in Development, 2021 SUMMARY Allergic Rhino-Conjunctivitis (Ophthalmology) - Drugs in Development, 2021 provides an overview of the Allergic Rhino...

April 2021 40 pages

Alopecia Areata (Dermatology) - Drugs in Development, 2021

US$ 2,000.00

Alopecia Areata (Dermatology) - Drugs in Development, 2021 SUMMARY Alopecia Areata (Dermatology) - Drugs in Development, 2021 provides an overview of the Alopecia Areata pipeline landscape. The report...

April 2021 60 pages

Alpha 1 Adrenergic Receptor (ADRA1) - Drugs in Development, 2021

US$ 3,000.00

Alpha 1 Adrenergic Receptor (ADRA1) - Drugs in Development, 2021 SUMMARY Alpha 1 Adrenergic Receptor (ADRA1) - Drugs in Development, 2021 provides in depth analysis on Alpha 1 Adrenergic Receptor (ADR...

April 2021 60 pages

Alpha 1 Antitrypsin (Alpha 1 Protease Inhibitor or Alpha 1 Antiproteinase or SERPINA1) - Drugs in Development, 2021

US$ 3,000.00

Alpha 1 Antitrypsin (Alpha 1 Protease Inhibitor or Alpha 1 Antiproteinase or SERPINA1) - Drugs in Development, 2021 SUMMARY Alpha 1 Antitrypsin (Alpha 1 Protease Inhibitor or Alpha 1 Antiproteinase or...

April 2021 60 pages

Alpha 1B Adrenergic Receptor (Alpha 1B Adrenoreceptor or ADRA1B) - Drugs in Development, 2021

US$ 3,000.00

Alpha 1B Adrenergic Receptor (Alpha 1B Adrenoreceptor or ADRA1B) - Drugs in Development, 2021 SUMMARY Alpha 1B Adrenergic Receptor (Alpha 1B Adrenoreceptor or ADRA1B) - Drugs in Development, 2021 prov...

April 2021 35 pages

Alpha 1D Adrenergic Receptor (Alpha 1A Adrenergic Receptor or Alpha 1D Adrenoreceptor or Alpha Adrenergic Receptor 1a or ADRA1D) - Drugs in Development, 2021

US$ 3,000.00

Alpha 1D Adrenergic Receptor (Alpha 1A Adrenergic Receptor or Alpha 1D Adrenoreceptor or Alpha Adrenergic Receptor 1a or ADRA1D) - Drugs in Development, 2021 SUMMARY Alpha 1D Adrenergic Receptor (Alph...

April 2021 30 pages

Alpha 2 Adrenergic Receptor (ADRA2) - Drugs in Development, 2021

US$ 3,000.00

Alpha 2 Adrenergic Receptor (ADRA2) - Drugs in Development, 2021 SUMMARY Alpha 2 Adrenergic Receptor (ADRA2) - Drugs in Development, 2021 provides in depth analysis on Alpha 2 Adrenergic Receptor (ADR...

April 2021 60 pages

Alpha Adrenergic Receptor (ADRA) - Drugs in Development, 2021

US$ 3,000.00

Alpha Adrenergic Receptor (ADRA) - Drugs in Development, 2021 SUMMARY Alpha Adrenergic Receptor (ADRA) - Drugs in Development, 2021 provides in depth analysis on Alpha Adrenergic Receptor (ADRA) targe...

April 2021 30 pages

Alport Syndrome (Genetic Disorders) - Drugs in Development, 2021

US$ 2,000.00

Alport Syndrome (Genetic Disorders) - Drugs in Development, 2021 SUMMARY Alport Syndrome (Genetic Disorders) - Drugs in Development, 2021 provides an overview of the Alport Syndrome pipeline landscape...

April 2021 35 pages

Amine Oxidase [Flavin Containing] A (Monoamine Oxidase Type A or MAOA or EC 1.4.3.4) - Drugs in Development, 2021

US$ 3,000.00

Amine Oxidase [Flavin Containing] A (Monoamine Oxidase Type A or MAOA or EC 1.4.3.4) - Drugs in Development, 2021 SUMMARY Amine Oxidase [Flavin Containing] A (Monoamine Oxidase Type A or MAOA or EC 1....

April 2021 35 pages

Amine Oxidase [Flavin Containing] B (Monoamine Oxidase Type B or MAOB or EC 1.4.3.4) - Drugs in Development, 2021

US$ 3,000.00

Amine Oxidase [Flavin Containing] B (Monoamine Oxidase Type B or MAOB or EC 1.4.3.4) - Drugs in Development, 2021 SUMMARY Amine Oxidase [Flavin Containing] B (Monoamine Oxidase Type B or MAOB or EC 1....

April 2021 55 pages

Amino Acid Metabolism Disorders (Genetic Disorders) - Drugs in Development, 2021

US$ 2,000.00

Amino Acid Metabolism Disorders (Genetic Disorders) - Drugs in Development, 2021 SUMMARY Amino Acid Metabolism Disorders (Genetic Disorders) - Drugs in Development, 2021 provides an overview of the Am...

April 2021 30 pages

Anal Fissure (Gastrointestinal) - Drugs in Development, 2021

US$ 2,000.00

Anal Fissure (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Anal Fissure (Gastrointestinal) - Drugs in Development, 2021 provides an overview of the Anal Fissure pipeline landscape. The repor...

April 2021 30 pages

Anaplastic Large Cell Lymphoma (ALCL) (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Anaplastic Large Cell Lymphoma (ALCL) (Oncology) - Drugs in Development, 2021 SUMMARY Anaplastic Large Cell Lymphoma (ALCL) (Oncology) - Drugs in Development, 2021 provides an overview of the Anaplast...

April 2021 115 pages

Anaplastic Thyroid Cancer (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Anaplastic Thyroid Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Anaplastic Thyroid Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Anaplastic Thyroid Cancer pipeli...

April 2021 65 pages

Androgen Receptor (Dihydrotestosterone Receptor or Nuclear Receptor Subfamily 3 Group C Member 4 or DHTR or NR3C4 or AR) - Drugs in Development, 2021

US$ 3,000.00

Androgen Receptor (Dihydrotestosterone Receptor or Nuclear Receptor Subfamily 3 Group C Member 4 or DHTR or NR3C4 or AR) - Drugs in Development, 2021 SUMMARY Androgen Receptor (Dihydrotestosterone Rec...

April 2021 160 pages

Androgen-Sensitive Prostate Cancer (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Androgen-Sensitive Prostate Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Androgen-Sensitive Prostate Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Androgen-Sensi...

April 2021 30 pages

Androgenic Alopecia (Dermatology) - Drugs in Development, 2021

US$ 2,000.00

Androgenic Alopecia (Dermatology) - Drugs in Development, 2021 SUMMARY Androgenic Alopecia (Dermatology) - Drugs in Development, 2021 provides an overview of the Androgenic Alopecia pipeline landscape...

April 2021 50 pages

Anemia of Chronic Disease (Hematological Disorders) - Drugs in Development, 2021

US$ 2,000.00

Anemia of Chronic Disease (Hematological Disorders) - Drugs in Development, 2021 SUMMARY Anemia of Chronic Disease (Hematological Disorders) - Drugs in Development, 2021 provides an overview of the An...

April 2021 30 pages

Angelman Syndrome (Genetic Disorders) - Drugs in Development, 2021

US$ 2,000.00

Angelman Syndrome (Genetic Disorders) - Drugs in Development, 2021 SUMMARY Angelman Syndrome (Genetic Disorders) - Drugs in Development, 2021 provides an overview of the Angelman Syndrome pipeline lan...

April 2021 50 pages

Angioimmunoblastic T-Cell Lymphoma (AITL)/Immunoblastic Lymphadenopathy (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Angioimmunoblastic T-Cell Lymphoma (AITL)/Immunoblastic Lymphadenopathy (Oncology) - Drugs in Development, 2021 SUMMARY Angioimmunoblastic T-Cell Lymphoma (AITL)/Immunoblastic Lymphadenopathy (Oncolog...

April 2021 100 pages

Angiopoietin 2 (Ang 2 or ANGPT2) - Drugs in Development, 2021

US$ 3,000.00

Angiopoietin 2 (Ang 2 or ANGPT2) - Drugs in Development, 2021 SUMMARY Angiopoietin 2 (Ang 2 or ANGPT2) - Drugs in Development, 2021 provides in depth analysis on Angiopoietin 2 (Ang 2 or ANGPT2) targe...

April 2021 45 pages

Angiopoietin Related Protein 3 (Angiopoietin 5 or Angiopoietin Like Protein 3 or ANG 5 or ANGPTL3) - Drugs in Development, 2021

US$ 3,000.00

Angiopoietin Related Protein 3 (Angiopoietin 5 or Angiopoietin Like Protein 3 or ANG 5 or ANGPTL3) - Drugs in Development, 2021 SUMMARY Angiopoietin Related Protein 3 (Angiopoietin 5 or Angiopoietin L...

April 2021 35 pages

Angiosarcoma (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Angiosarcoma (Oncology) - Drugs in Development, 2021 SUMMARY Angiosarcoma (Oncology) - Drugs in Development, 2021 provides an overview of the Angiosarcoma pipeline landscape. The report provides compr...

April 2021 50 pages

Angiotensin Converting Enzyme (Dipeptidyl Carboxypeptidase I or Kininase II or CD143 or ACE or EC 3.4.15.1 or EC 3.2.1.) - Drugs in Development, 2021

US$ 3,000.00

Angiotensin Converting Enzyme (Dipeptidyl Carboxypeptidase I or Kininase II or CD143 or ACE or EC 3.4.15.1 or EC 3.2.1.) - Drugs in Development, 2021 SUMMARY Angiotensin Converting Enzyme (Dipeptidyl...

April 2021 40 pages

Anorexia Nervosa (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Anorexia Nervosa (Central Nervous System) - Drugs in Development, 2021 SUMMARY Anorexia Nervosa (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Anorexia Nervosa pipel...

April 2021 35 pages

Anterior Uveitis (Ophthalmology) - Drugs in Development, 2021

US$ 2,000.00

Anterior Uveitis (Ophthalmology) - Drugs in Development, 2021 SUMMARY Anterior Uveitis (Ophthalmology) - Drugs in Development, 2021 provides an overview of the Anterior Uveitis pipeline landscape. The...

April 2021 45 pages

Anthrax Protective Antigen (pa) - Drugs in Development, 2021

US$ 3,000.00

Anthrax Protective Antigen (pa) - Drugs in Development, 2021 SUMMARY Anthrax Protective Antigen (pa) - Drugs in Development, 2021 provides in depth analysis on Anthrax Protective Antigen (pa) targeted...

April 2021 35 pages

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) (Immunology) - Drugs in Development, 2021

US$ 2,000.00

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) (Immunology) - Drugs in Development, 2021 SUMMARY Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculit...

April 2021 30 pages

Antiphospholipid Syndrome (Hematological Disorders) - Drugs in Development, 2021

US$ 2,000.00

Antiphospholipid Syndrome (Hematological Disorders) - Drugs in Development, 2021 SUMMARY Antiphospholipid Syndrome (Hematological Disorders) - Drugs in Development, 2021 provides an overview of the An...

April 2021 30 pages

Antithrombin III (ATIII or SERPINC1) - Drugs in Development, 2021

US$ 3,000.00

Antithrombin III (ATIII or SERPINC1) - Drugs in Development, 2021 SUMMARY Antithrombin III (ATIII or SERPINC1) - Drugs in Development, 2021 provides in depth analysis on Antithrombin III (ATIII or SER...

April 2021 35 pages

Anxiety Disorders (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Anxiety Disorders (Central Nervous System) - Drugs in Development, 2021 SUMMARY Anxiety Disorders (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Anxiety Disorders pi...

April 2021 140 pages

Aortic Valve Stenosis (Cardiovascular) - Drugs in Development, 2021

US$ 2,000.00

Aortic Valve Stenosis (Cardiovascular) - Drugs in Development, 2021 SUMMARY Aortic Valve Stenosis (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Aortic Valve Stenosis pipeli...

April 2021 35 pages

Apolipoprotein A (APOA or LPA) - Drugs in Development, 2021

US$ 3,000.00

Apolipoprotein A (APOA or LPA) - Drugs in Development, 2021 SUMMARY Apolipoprotein A (APOA or LPA) - Drugs in Development, 2021 provides in depth analysis on Apolipoprotein A (APOA or LPA) targeted pi...

April 2021 30 pages

Apolipoprotein A I (APOA1) - Drugs in Development, 2021

US$ 3,000.00

Apolipoprotein A I (APOA1) - Drugs in Development, 2021 SUMMARY Apolipoprotein A I (APOA1) - Drugs in Development, 2021 provides in depth analysis on Apolipoprotein A I (APOA1) targeted pipeline thera...

April 2021 35 pages

Apolipoprotein C III (APOC3) - Drugs in Development, 2021

US$ 3,000.00

Apolipoprotein C III (APOC3) - Drugs in Development, 2021 SUMMARY Apolipoprotein C III (APOC3) - Drugs in Development, 2021 provides in depth analysis on Apolipoprotein C III (APOC3) targeted pipeline...

April 2021 35 pages

Apolipoprotein E (APOE) - Drugs in Development, 2021

US$ 3,000.00

Apolipoprotein E (APOE) - Drugs in Development, 2021 SUMMARY Apolipoprotein E (APOE) - Drugs in Development, 2021 provides in depth analysis on Apolipoprotein E (APOE) targeted pipeline therapeutics....

April 2021 45 pages

Apolipoprotein L1 (Apolipoprotein L or APOL1) - Drugs in Development, 2021

US$ 3,000.00

Apolipoprotein L1 (Apolipoprotein L or APOL1) - Drugs in Development, 2021 SUMMARY Apolipoprotein L1 (Apolipoprotein L or APOL1) - Drugs in Development, 2021 provides in depth analysis on Apolipoprote...

April 2021 30 pages

Apoptosis Regulator Bcl 2 (Protein Phosphatase 1 Regulatory Subunit 50 or BCL2) - Drugs in Development, 2021

US$ 3,000.00

Apoptosis Regulator Bcl 2 (Protein Phosphatase 1 Regulatory Subunit 50 or BCL2) - Drugs in Development, 2021 SUMMARY Apoptosis Regulator Bcl 2 (Protein Phosphatase 1 Regulatory Subunit 50 or BCL2) - D...

April 2021 35 pages

Appetite (Eating) Disorders (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Appetite (Eating) Disorders (Central Nervous System) - Drugs in Development, 2021 SUMMARY Appetite (Eating) Disorders (Central Nervous System) - Drugs in Development, 2021 provides an overview of the...

April 2021 35 pages

Aquaporin 4 (Mercurial Insensitive Water Channel or WCH4 or AQP4) - Drugs in Development, 2021

US$ 3,000.00

Aquaporin 4 (Mercurial Insensitive Water Channel or WCH4 or AQP4) - Drugs in Development, 2021 SUMMARY Aquaporin 4 (Mercurial Insensitive Water Channel or WCH4 or AQP4) - Drugs in Development, 2021 pr...

April 2021 30 pages

Arachidonate 15 Lipoxygenase (12/15 Lipoxygenase or Arachidonate 12 Lipoxygenase Leukocyte Type or Arachidonate Omega 6 Lipoxygenase or ALOX15 or EC 1.13.11.33 or EC 1.13.11.31) - Drugs in Development, 2021

US$ 3,000.00

Arachidonate 15 Lipoxygenase (12/15 Lipoxygenase or Arachidonate 12 Lipoxygenase Leukocyte Type or Arachidonate Omega 6 Lipoxygenase or ALOX15 or EC 1.13.11.33 or EC 1.13.11.31) - Drugs in Development...

April 2021 30 pages

Arachidonate 5 Lipoxygenase (5 Lipoxygenase or Leukotriene A4 Synthase or ALOX5 or EC 1.13.11.34) - Drugs in Development, 2021

US$ 3,000.00

Arachidonate 5 Lipoxygenase (5 Lipoxygenase or Leukotriene A4 Synthase or ALOX5 or EC 1.13.11.34) - Drugs in Development, 2021 SUMMARY Arachidonate 5 Lipoxygenase (5 Lipoxygenase or Leukotriene A4 Syn...

April 2021 40 pages

Arachidonate 5 Lipoxygenase Activating Protein (MK 886 Binding Protein or FLAP or ALOX5AP) - Drugs in Development, 2021

US$ 3,000.00

Arachidonate 5 Lipoxygenase Activating Protein (MK 886 Binding Protein or FLAP or ALOX5AP) - Drugs in Development, 2021 SUMMARY Arachidonate 5 Lipoxygenase Activating Protein (MK 886 Binding Protein o...

April 2021 30 pages

Arenaviridae Infections (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Arenaviridae Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Arenaviridae Infections (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Arenaviridae Inf...

April 2021 30 pages

Filters

Clear all